Teva improves the lives of patients around the world every day with our quality medicines, and we want to continue to do so for many years. Our long-term sustainability depends on us operating responsibly and making a positive impact in the areas that are important to our company and our stakeholders.
We have a defined Environmental, Social and Governance (ESG) strategy — and we set measurable targets, many of which are tied to sustainable finance instruments, to hold us accountable and drive action. Here are some highlights of how we advanced these efforts last year..
Minimizing our impact on the planet
Advancing health and equity
30.4M doses of essential medicines (worth $11.5M) donated to Ukrainian people, largest donation of any pharmaceutical company at the time
21 new regulatory submissions in low- and middle-income countries (LMICs) (28% of 2025 target)
80%↓ reduction in total recordable incident rate, a measure of employee safety, over the last decade
$44B in savings from generic medicines across 21 countries
5 access to medicines programs launched as of 2022 (63% of 2025 target of 8 access programs)
82% employee satisfaction with Teva’s inclusion and diversity practices
*Based on 2022 Teva Organizational Health Survey
$44B in savings from generic medicines across 21 countries
Dedicating ourselves to quality, ethics and transparency
11.5% of procurement spend in the US allocated to small, diverse businesses
Approximately 100% of active employees and 93.8% of new employees trained on compliance policies
More than half of critical suppliers assessed on ESG performance (56% of 2025 target)
Reduced total scope 1 and 2 GHG emissions by 24%↓ (vs. 2019) |
Reduced total scope 3 GHG emissions by 12%↓ (vs. 2020) | Increased total proportion of electricity purchased or generated from renewable sources to 41%↑ |
Greenhouse gas (GHG) emissions reduction targets (scope 1, 2 and 3) validated by Science Based Targets initiative (SBTi) |
11.5% of procurement spend in the US allocated to small, diverse businesses | Approximately 100% of active employees and 93.8% of new employees trained on compliance policies | More than half of critical suppliers assessed on ESG performance (56% of 2025 target) |